Author:
Kappas A.,Cogliano V. J.,Watanabe K.,Zapponi G. A.
Reference229 articles.
1. Allen, B. C. and Fisher, J. W. (1993). Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Anal. 13, 71–86.
2. Amdur, M. O., Doull, J. and Klaassen, C. D. (Eds.) (1991). Casarett and Doull’s Toxicology (4th ed.). McGraw-Hill, Inc., New York.
3. Andersen, M. E., Archer, R. L., Clewell, H. J. and MacNaughton, M. G. (1984). A physiological model of the intravenous and inhalation pharmacokinetics of three dihalomethanes. Toxicologist 4, 443.
4. Andersen, M. E., Clewell III, H. J., Gargas, M. L., Smith, F. A. and Reitz, R. H. (1987a). Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87, 185–205.
5. Andersen, M. E., Gargas, M. L., Clewell, H. J., III and Severyn, K. M. (1987b). Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods. Toxicol. Appl. Pharmacol. 89, 149–157.